19. November 2009 22:37
People with arthritis and leading Canadian and international researchers will share the stage under the theme "Decoding Arthritis - A Joint Effort" when the Canadian Arthritis Network (CAN) hosts its 2009 Annual Scientific Conference beginning tonight, in Vancouver, BC.
[More]
19. November 2009 06:30
A panel of osteoarthritis (OA) key opinion leaders has developed a consensus of the optimal exogenous hyaluronic acid (HA) treatment. This consensus was achieved by utilizing what the experts referred to as BioRestorative(TM) Profiling. This profiling examines HAs on the basis of their mimicking the body's natural HA.
[More]
18. November 2009 03:49
GliaMed, Inc., a development stage biopharmaceutical company, today announced that Dr. David Weinstein, chief scientific officer and company founder, will present pre-clinical data demonstrating acceleration of wound healing through the in vivo induction and recruitment of stem cells at the Stem Cells USA & Regenerative Medicine Congress in Washington, D.C.
[More]
18. November 2009 02:23
Researchers at the University of Pittsburgh and the University of Iowa will lead a $9 million, five-year initiative to study the cause of facial birth defects. The FaceBase Consortium will create an encyclopedic database of how the faces of children develop and what goes wrong to cause malformations.
[More]
17. November 2009 05:07
Research and Markets (http://www.researchandmarkets.com/research/1ed71c/bone_and_soft_tiss) has announced the addition of the "Bone and Soft Tissue Pathology for the Surgical Pathologist" report to their offering.
[More]
16. November 2009 07:40
SANUWAVE Health, Inc.,, an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reports its achievements and financial results for the three and nine months ended September 30, 2009.
[More]
1f1947f1-20f1-46fb-b97c-0a3bd82b41f5|0|.0
Posted in: Business / Finance
Tags: Bone, Cartilage, Hospital, Orthopedic, Plantar fasciitis, Plastic Surgery, Spine, Tendonitis, Tissue Engineering, Ulcer, Wound Healing
16. November 2009 07:37
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
[More]
13. November 2009 04:10
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton.
[More]
ca347ad3-05ea-48a5-af3e-e9bf6dc9eced|0|.0
Posted in: Medical Science News
Tags: Amino Acid, Arginine, Arthritis, Bone, Bone Morphogenetic Protein, Cartilage, Cell, DNA, Education, Gene Expression, Genetics, Hospital, Nursing, Orthopedic, Trauma
13. November 2009 00:53
Varian, Inc. announced today that Steady State Imaging (SSI) has signed a reseller's agreement with Varian, Inc. regarding SSI's new SWIFT Software for Varian's research MRI Systems. SWIFT is a novel MRI technology that advances existing MR techniques with the ability to silently image structures and tissues previously invisible to conventional MRI systems.
[More]
12. November 2009 01:05
Kensey Nash Corporation, a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance for its first extracellular matrix (ECM) product, Medeor(TM) Matrix, from the U.S. Food and Drug Administration.
[More]
9. November 2009 10:53
LifeNet Health, a leading allograft bio-implant company, announces the launch of Vertigraft Cervical Bio-Implant (VG2C) with Preservon® Technology
[More]
9. November 2009 09:18
Emisphere Technologies, Inc. today announced financial and operational results for the third quarter and nine months ended September 30, 2009.
[More]
44838c5a-477c-4ce4-97c9-ba6a814f1c7c|0|.0
Posted in: Business / Finance | Drug Trial News
Tags: Arthritis, Bone, Calcitonin, Cartilage, Drug Delivery, Gastroenterology, Hospital, Insulin, Osteoarthritis, Osteoporosis, Pharmacology, Rheumatology, Toxicology
4. November 2009 01:58
A new study published in Nutrition Journal indicates that XanGo- Juice, a market-leading, premium mangosteen beverage, has lowered levels of C-reactive protein (CRP) in overweight and obese people in a randomized, double-blind, placebo-controlled human trial.
[More]
3. November 2009 23:44
BioMimetic Therapeutics, Inc. announced today that it has received approval from Health Canada to begin the marketing of its lead orthopedic product, Augment™ Bone Graft, as an alternative to the use of autograft in midfoot, hindfoot and ankle fusion indications in Canada.
[More]
3. November 2009 08:13
Arrowhead Research Corporation’s (NASDAQ: ARWR) President and Chief Executive Officer today issued the following letter to the Company’s shareholders.
[More]
21556903-81bd-487b-b714-090b9fb3fb9b|0|.0
Posted in: Business / Finance
Tags: Bone, Burn, Cancer, Carbon Nanotube, Cartilage, Cell, Drug Delivery, Investment, Nanotechnology, Paralysis, siRNA
Subscribe